Myoclonus Therapy
New myoclonus therapy study findings have been published by scientists at University of Amsterdam, Department of Neurology
Published in Drug Law Weekly, March 31st, 2009
Data detailed in 'Reduced striatal D2 receptor binding in myoclonus-dystonia' have been presented. In this recent report, researchers in Amsterdam, Netherlands conducted a study "To study striatal dopamine D(2) receptor availability in DYT11 mutation carriers of the autosomal dominantly inherited disorder myoclonus-dystonia (M-D). Fifteen DYT11 mutation carriers (11 clinically affected) and 15 age-and sex-matched controls were studied using (123)I-IBZM SPECT."
"Specific striatal binding ratios were calculated using standard templates for striatum and occipital areas. Multivariate analysis with corrections for aging and smoking showed significantly lower specific...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-03-31)
More Articles from Drug Law Weekly
- Allergies
Food Allergy Initiative to Partner With NYC Department of Health on Educational Poster for Restaurants Citywide - AllOne Health
AllOne Health to Provide Background Checks for Employers - Arbios Systems, Inc.
Arbios Announces Intent to File a Reorganization Plan - BioSante Pharmaceuticals, Inc.
BioSante Pharmaceuticals Reports LibiGelŪ Status and Financial Results for 2008 - Cancer
U.S. Rep. Connolly, Inova Hospital Physicians, Public Health Groups Call for Congressional Action to Protect Kids From Tobacco - Cancer Vaccines
Medical Tourism - Choosing a Mexican Cancer Clinic - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
